IRIS

ZANARDI, ELISA

ZANARDI, ELISA  

100007 - Dipartimento di Medicina interna e specialità mediche  

Mostra records
Risultati 1 - 20 di 61 (tempo di esecuzione: 0.047 secondi).
Titolo Data di pubblicazione Autore(i) File
861P Time to castration resistant prostate cancer (CRPC) and the risk of developing immune disorders 1-gen-2019 Conteduca, V; Caffo, O; Scarpi, E; Sepe, P; Galli, L; Fratino, L; Maines, F; E Chiuri, V; Santoni, M; Zanardi, E; Massari, F; Toma, I; Schepisi, G; Sbrana, A; Kinspergher, S; C Cursano, M; Modonesi, C; Davide, Santini; Procopio, G; F De Giorgi, U F
A Case of Plasmacytoid Variant of Bladder Cancer with a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature 1-gen-2016 Messina, Carlo; Zanardi, Elisa; Dellepiane, Chiara; Tomasello, Laura; Colecchia, Maurizio; Ravetti, GIAN LUIGI; Boccardo, Francesco; Spina, Bruno
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 1-gen-2019 Cattrini, C; Zanardi, E; Rubagotti, A; Zinoli, L; Capaia, M; Barboro, P; Boccardo, F.
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 1-gen-2017 Boccardo, F; Cavo, A; Zanardi, E; Fabbroni, C; Zinoli, L; Di Meglio, A; Arboscello, E; Bellodi, A; Spallarossa, P; Cattrini, C; Messina, C; Rubagotti, A
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 1-gen-2018 Cavo, Alessia; Rubagotti, Alessandra; Zanardi, Elisa; Fabbroni, Chiara; Zinoli, Linda; Di Meglio, Antonio; Arboscello, Eleonora; Bellodi, Andrea; Spallarossa, Paolo; Cattrini, Carlo; Messina, Carlo; Boccardo, Francesco
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey 1-gen-2016 Diminutto, Alberto; Basso, Umberto; Maruzzo, Marco; Morelli, Franco; De Giorgi, Ugo; Perin, Alessandra; Fraccon, Anna Paola; Lo Re, Giovanni; Rizzi, Anna; Sava, Teodoro; Fornarini, Giuseppe; Valcamonico, Francesca; Zustovich, Fable; Massari, Francesco; Zanardi, Elisa; Roma, Anna; Zattoni, Filiberto; Zagonel, Vittorina
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival 1-gen-2013 Garbay, D.; Maki, R. G.; Blay, J. Y.; Isambert, N.; Piperno Neumann, S.; Blay, C.; Zanardi, E.; Boudou-Rouquette, P.; Bozec, L.; Duffaud, F.; Bertucci, F.; Italiano, A.
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer 1-gen-2018 Cattrini, Carlo; Zanardi, Elisa; Boccardo, Francesco
Baseline 18F-Fluoride PET-derived parameters predict modification of toxicity-and response-related blood biomarkers in prostate cancer patients treated with 223Ra-Dichloride: preliminary results 1-gen-2017 Ceriani, V; Fornarini, G; Bauckneht, M; Morbelli, S; Zanardi, E; Pomposelli, E; Buschiazzo, A; Calamia, I; Ippoliti, M; Fiz, F; Piva, R; Bettini, Pm; Boccardo, F; Sambuceti, G
Better Together: Immunotherapy as Future Combination Strategy for Breast Cancer 1-gen-2016 Zanardi, Elisa
Better Together: Targeted Combination Therapies in Breast Cancer 1-gen-2015 Zanardi, Elisa; Bregni, Giacomo; de Braud, Filippo; Di Cosimo, Serena
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management 1-gen-2022 Borea, Roberto; Favero, Diletta; Miceli, Alberto; Donegani, Maria Isabella; Raffa, Stefano; Gandini, Annalice; Cremante, Malvina; Marini, Cecilia; Sambuceti, Gianmario; Zanardi, Elisa; Morbelli, Silvia; Fornarini, Giuseppe; Rebuzzi, Sara Elena; Bauckneht, Matteo
Bone metastases from prostate cancer: hormonal therapy 1-gen-2017 Zanardi, Elisa; Cattrini, Carlo; Boccardo, Francesco
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications 1-gen-2020 Messina, Carlo; Cattrini, Carlo; Soldato, Davide; Vallome, Giacomo; Caffo, Orazio; Castro, Elena; Olmos, David; Boccardo, Francesco; Zanardi, Elisa
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT 1-gen-2023 Gandini, Annalice; Bauckneht, Matteo; Sofia, Luca; Tomasello, Laura; Fornarini, Giuseppe; Zanardi, Elisa
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study 1-gen-2017 Cavo, A; Rubagotti, A; Bellodi, A; Zanardi, E; Zinoli, L; Spallarossa, P; Bagnato, P; Pane, B; Favorini, S; Barra, S; Arboscello, C; Arboscello, E; Palombo, D; Boccardo, F
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients 1-gen-2022 Boutros, Andrea; Vera, Lara; Gatto, Federico; Fornarini, Giuseppe; Zanardi, Elisa
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials 1-gen-2018 Messina, Carlo; Cattrini, Carlo; Buzzatti, Giulia; Cerbone, Luigi; Zanardi, Elisa; Messina, Marco; Boccardo, Francesco
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study 1-gen-2016 Bruzzone, M; Dellepiane, C; Bo, E; Cavo, A; Giannelli, F; Centurioni, Mg; Cosso, M; Alessandri, F; Vellone, VALERIO GAETANO; Sirito, R; Zanardi, Elisa; Buzzatti, G; Messina, C; Cattrini, C; Gustavino, C; Boccardo, Francesco
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 1-gen-2015 Zanardi, Elisa; Verzoni, Elena; Grassi, Paolo; Necchi, Andrea; Giannatempo, Patrizia; Raggi, Daniele; De Braud, Filippo; Procopio, Giuseppe